{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:16:32Z","timestamp":1768432592036,"version":"3.49.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":53,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Although von Willebrand disease (VWD) is a common inherited bleeding disorder, very few cases of surgery in patients with VWD have been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case:<\/jats:title>\n                    <jats:p>A 77-year-old man was referred to our hospital for treatment of hepatocellular carcinoma (HCC) based on type C chronic hepatitis. He had also been treated for VWD in the hematology department of another hospital. Partial hepatectomy was performed with the administration of factor VIII\/von Willebrand factor concentrate just before and after the operation. The perioperative course was uneventful, and the patient was discharged 12 days after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>VWD causes dysfunction of the platelet and destabilization of the blood clotting factor VIII. The patient was successfully treated with measurement of activated partial thromboplastin time (APTT) as an index for the management of hemostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This report describes a rare case of a successful perioperative management of hepatectomy in a patient with VWD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2018.02.033","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T02:36:42Z","timestamp":1519439802000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease"],"prefix":"10.1097","volume":"44","author":[{"given":"Koki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-33-20260114","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/hae.12378","article-title":"A successful case of right hepatectomy in a patient with von Willebrand disease","volume":"20","author":"Kokudo","year":"2014","journal-title":"Haemophilia"},{"key":"R2-33-20260114","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijsu.2016.11.021","article-title":"Erratum to The SCARE guidelines: consensus-based surgical case report guidelines [Int. J. Surg. 34 (2016) 180-186]","volume":"36","author":"Agha","year":"2016","journal-title":"Int. J. Surg"},{"key":"R3-33-20260114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1050-1738(00)00019-0","article-title":"Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex","volume":"9","author":"Saenko","year":"1999","journal-title":"Trends Cardiovasc. Med"},{"key":"R4-33-20260114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2516.1999.0050s2007.x","article-title":"The history of von Willebrand disease","volume":"5","author":"Nilsson","year":"1999","journal-title":"Haemophilia"},{"key":"R5-33-20260114","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Humate PSG: Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy","volume":"9","author":"Gill","year":"2003","journal-title":"Haemophilia"},{"key":"R6-33-20260114","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the national heart, lung, and blood institute (NHLBI) expert panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"R7-33-20260114","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF03005587","article-title":"Perioperative management of patients with von Willebrand's disease","volume":"37","author":"Cameron","year":"1990","journal-title":"Can. J. Anaesth"},{"key":"R8-33-20260114","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/ajh.23142","article-title":"von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies","volume":"87","author":"James","year":"2012","journal-title":"Am. J. Hematol"},{"key":"R9-33-20260114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000379759","article-title":"Administration of antithrombin III attenuates posthepatectomy liver failure in hepatocellular carcinoma","volume":"32","author":"Kuroda","year":"2015","journal-title":"Dig. Surg"},{"key":"R10-33-20260114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2044.2007.05001.x","article-title":"Peri-operative management of an adult patient with type 2N von Willebrand's disease scheduled for coronary artery bypass graft","volume":"62","author":"Gerling","year":"2007","journal-title":"Anaesthesia"},{"key":"R11-33-20260114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"key":"R12-33-20260114","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00381-015-2875-3","article-title":"Syringomyelia following surgery for a spontaneous spinal subdural hematoma in a 13-year-old girl with congenital von Willebrand disease: case report and literature review","volume":"32","author":"Ben Nsir","year":"2016","journal-title":"Childs Nerv. Syst"},{"key":"R13-33-20260114","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","article-title":"Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb. Haemost"},{"key":"R14-33-20260114","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218300671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261218300671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201844000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:10:09Z","timestamp":1768396209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201844000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":14,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2018.02.033","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}